Pacemaker Infection Treatment Drugs Market

Cardiac implant placement rate is growing over time as increasing cardiac disorders. As significant benefits of cardiac implants, cardiac implantable devices such as pacemaker and left ventricular assist devices have witnessed significant demand. Rise of infection associated with the pacemaker implant needs appropriate treatment. Antibiotic and antifungal medicines are prescribed for pacemaker infection treatment.

Antibiotic plays an important role in the patients whose devices cannot be removed and poor candidate for cardiac surgery. Pacemaker infection leads to significant healthcare cost, lengthy hospital stays and leads to mortality.

Pacemaker Infection is the most common reason for the bacterial exposure at the time of implantation, revision, and replacement of the device. Antimicrobial therapy is commonly prescribed therapy for pacemaker infection treatment.

Duration, quantity, and type of drug depend upon the pathogen or infection. Antimicrobial therapy should be provided at least 4 to 6 weeks for complicated infections such as septic thrombophlebitis, endocarditis, and osteomyelitis.

The growing number of pacemaker related infection cases expected to drive the growth of the pacemaker infection treatment market. Increasing awareness among the general population regarding surgical site infections expected to propel the growth of the pacemaker infection treatment market.

Increasing aging population, growing healthcare expenditure expected boost up the growth of the pacemaker infection treatment market. Increasing prevalence of cardiac diseases expected to propel the growth of the pacemaker infection treatment market.

The high rate of smoking and increased tobacco use can fuel the pacemaker infection treatment market. Advancement in technology and treatment option expected to favors the growth of the pacemaker infection treatment market.

The growing number of clinical trials and drug development procedure expected to favor the growth of the pacemaker infection treatment market. Increasing new antibacterial and antimicrobial drug approval flourish the growth of the pacemaker infection treatment market.

• Pacemaker Infection Treatment Market Segments
• Pacemaker Infection Treatment Market Dynamics
• Historical Actual Market Size, 2014 - 2018
• Pacemaker Infection Treatment Market Size & Forecast 2019 to 2029
• Pacemaker Infection Treatment Market Current Trends/Issues/Challenges
• Competition & Companies involved
• Pacemaker Infection Treatment Market Drivers and Restraints

• Shifting industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size recent industry trends
• Key competition landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance